MET: Difference between revisions
From Pharmacopedia
More actions
| [checked revision] | [pending revision] |
MDElliottMD (talk | contribs) Pharmacopedia: add <pharmaInteractions/> |
MDElliottMD (talk | contribs) home-claude: Erowid dosing (erowid-claude source; URLs verified; em-dash clean) |
||
| (4 intermediate revisions by 2 users not shown) | |||
| Line 21: | Line 21: | ||
| indications = | | indications = | ||
| dosing = | | dosing = | ||
<titration slug="erowid-dose-multi-route" author="erowid-claude" | |||
title="Multi-route dose ladders (Erowid, very tentative)"> | |||
Erowid's dosage documentation for MET<ref name="erowid-met-dose"> | |||
Erowid. MET Dosage. Erowid.org. | |||
https://www.erowid.org/chemicals/met/met_dose.shtml. | |||
Accessed 2026-05-25.</ref> is marked "very tentative" by Erowid, | |||
given limited reports. The following tiers are reported: | |||
'''Oral:''' | |||
* Light: 60-120 mg; Common: 80-150 mg; Strong: 150+ mg | |||
* (Threshold not characterized; timing not provided) | |||
'''Vaporized:''' | |||
* Threshold: ~8 mg; Light: 10-20 mg; Common: 15-30 mg; Strong: 30-40+ mg | |||
'''Insufflated:''' | |||
* Light: 10-20 mg; Common: 15-25 mg | |||
'''Intramuscular:''' | |||
* Common: 10-30 mg; Strong: 30-50+ mg | |||
The wide disparity between oral (60+ mg) and vaporized (8+ mg) tiers | |||
is a pharmacokinetic feature of the tryptamine class generally, and | |||
is particularly marked for MET. Erowid's own tentative qualification | |||
should be reflected in any presentation of these figures. | |||
</titration> | |||
| effects = | | effects = | ||
| interactions = <pharmaInteractions/> | | interactions = <pharmaInteractions/> | ||
| Line 31: | Line 57: | ||
}} | }} | ||
[[Category: | |||
[[Category:Research chemicals]] | |||
[[Category:Tryptamines]] | |||
[[Category:Classical Psychedelics (Serotonergic)]] | |||
[[Category:Psychedelics]] | |||